Authors: DUVAUCHELLE T MILLERIOUX L GUALANO V EVENE E ALCAIDE A

Citation: T. Duvauchelle et al., COMPARATIVE BIOAVAILABILITY STUDY OF 2 ORAL OMEPRAZOLE FORMULATIONS AFTER SINGLE AND REPEATED ADMINISTRATIONS IN HEALTHY-VOLUNTEERS, Clinical drug investigation, 16(2), 1998, pp. 141-149

Authors: TRANCHAND B CATIMEL G LUCAS C SARKANY M BASTIAN G EVENE E GUASTALLA JP NEGRIER S REBATTU P DUMORTIER A FOY M GROSSIN F MAZIER B FROUDARAKIS M BARBET N CLAVEL M ARDIET C

Citation: B. Tranchand et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF S9788, A NEW MULTIDRUG-RESISTANCE REVERSAL AGENT GIVEN ALONE AND IN COMBINATION WITH DOXORUBICIN TO PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 281-291

Authors: EVENE E CHATELUT E TRANCHAND B CANAL P LOCHON I ILIADIS A ARDIET CJ

Citation: E. Evene et al., BAYESIAN-ESTIMATION OF ETOPOSIDE PHARMACO KINETIC PARAMETERS, Bulletin du cancer, 84(7), 1997, pp. 699-703

Authors: DIRIX L CATIMEL G KOIER I PROVE A SCHRIJVERS D JOOSSENS E DEBRUIJN E ARDIET C EVENE E DUMORTIER A CLAVEL M VANOOSTEROM A

Citation: L. Dirix et al., PHASE-I AND PHARMACOKINETIC STUDY OF A NOVEL MITOMYCIN-C ANALOG KW-2149, Anti-cancer drugs, 6(1), 1995, pp. 53-63